Canntab Therapeutics Ltd said it has appointed Hamish Sutherland as a strategic business consultant to develop additional sales and distribution channels for the company’s products and to assist it in reaching strategic partnerships in the cannabis industry.
A seasoned veteran of the legal cannabis industry in Canada with over nine years of experience, Sutherland’s past achievements include the role of founding chief operating officer of Bedrocan Canada Inc., delivering over $750 million in investor value and overseeing the building and commissioning of two licensed facilities, including a 52,000 square foot state-of-the-art automated facility in suburban Toronto.
READ: Canntab Therapeutics inks affiliate deal with independent pharmacy owners in Ontario
"We are very pleased to have Hamish join our team. Mr. Sutherland's deep operational expertise in the cannabis industry specifically in the areas of finance, capital markets and corporate strategy will expand the skills matrix of the Canntab team, with the goal of generating one or more transactions to enhance shareholder value," said Larry Latowsky, CEO of Canntab, in a statement.
Sutherland also serves as officer and director of various public and private cannabis companies in Canada, US and Australia, including Indiva Inc., Mera Cannabis Corp., Altopa Inc. and Asterion Cannabis Inc. he holds an MBA from the Schulich School of Business at York University and a degree in Engineering Physics from McMaster University.
Sutherland's engagement is four months initially but can be extended on a month-to-month basis for an additional two months. He will receive $5,000 a month and has been issued 40,000 common shares of Canntab. In addition, Canntab has also granted 200,000 stock options to him exercisable at $0.50 per share for a period of four years. He will also be entitled to finder's fees for any strategic initiative completed or which he introduces to the company.
Contact the author at jon.hopkins@proactiveinvestors.com